G-CSF could ameliorate and improve hepatic steatosis by reducing the expression of SREBP-1c (74), a transcription factor, inductor of hepatic lipogenesis and mobilizing bone marrow cells, which contributes to liver regeneration (75). This evidence concerns the gene CSF3 and fatty liver disease.